Cytosorbents CorporationCTSONASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P5
Near historical low
vs 5Y Ago
-3.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -260.77% |
| Q2 2025 | 227.98% |
| Q1 2025 | 82.64% |
| Q4 2024 | -226.34% |
| Q3 2024 | 43.77% |
| Q2 2024 | 30.64% |
| Q1 2024 | 15.38% |
| Q4 2023 | 38.10% |
| Q3 2023 | -50.00% |
| Q2 2023 | 17.65% |
| Q1 2023 | -865.91% |
| Q4 2022 | 93.71% |
| Q3 2022 | -12.00% |
| Q2 2022 | -19.05% |
| Q1 2022 | 4.55% |
| Q4 2021 | -46.67% |
| Q3 2021 | -36.36% |
| Q2 2021 | -10.00% |
| Q1 2021 | -513.50% |
| Q4 2020 | 19.31% |
| Q3 2020 | 74.30% |
| Q2 2020 | 21.40% |
| Q1 2020 | 16.67% |
| Q4 2019 | 42.86% |
| Q3 2019 | -90.91% |
| Q2 2019 | 26.67% |
| Q1 2019 | 11.76% |
| Q4 2018 | -77.08% |
| Q3 2018 | 49.47% |
| Q2 2018 | -90.00% |
| Q1 2018 | 9.09% |
| Q4 2017 | -57.14% |
| Q3 2017 | -16.67% |
| Q2 2017 | 0.00% |
| Q1 2017 | 64.71% |
| Q4 2016 | -54.55% |
| Q3 2016 | 8.33% |
| Q2 2016 | -65.98% |
| Q1 2016 | 11.83% |
| Q4 2015 | 25.45% |